11-hydroxy-n-(n-propyl)noraporphine has been researched along with valerates in 1 studies
Studies (11-hydroxy-n-(n-propyl)noraporphine) | Trials (11-hydroxy-n-(n-propyl)noraporphine) | Recent Studies (post-2010) (11-hydroxy-n-(n-propyl)noraporphine) | Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) |
---|---|---|---|---|---|
11 | 0 | 2 | 2,251 | 294 | 457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisher, R; Jackson, MJ; Jenner, P; Lees, AJ; Lincoln, L; Neumeyer, J; Rose, S; Sromek, AW | 1 |
1 review(s) available for 11-hydroxy-n-(n-propyl)noraporphine and valerates
Article | Year |
---|---|
Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
Topics: Animals; Apomorphine; Aporphines; Behavior, Animal; Callithrix; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Male; MPTP Poisoning; Valerates | 2016 |